Mineralocorticoid receptor (MR) activation promotes inflammation, oxidative stress, obesity-associated coronary microvascular dysfunction, cardiac and arterial fibrotic remodeling and calcification [2, 8, 9, 28, 33]. Here, NR3C2 is linked to obesity due to melanocortin 4 receptor deficiency.